Skip to content
BetModernHub

Zimbabwe Turns Down ‘Unbalanced’ US Health Aid Deal Due to Data Concerns

Health funding illustration
The proposed American financial assistance was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years due to Washington's request for confidential information.

This rejection came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "lopsided".

A government representative has since stated that the United States was seeking health data for research and commercial gain but was unwilling to guarantee the resulting advantages from any future treatments.

"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged further dialogue to find a agreement acceptable to all parties so the nation's critical HIV programme can proceed.

Wider Implications

This rejection comes after a comparable case in neighbouring Kenya, where a court suspended a similar deal with the US following concerns were raised about the safety of citizens' medical information.

Since returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and responsibility.

As per statements, Sixteen African countries have to date agreed to similar health pacts, constituting over $18.3bn in committed funds.

Details of the Declined Agreement

The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this collaboration could have provided immense benefits for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy via US-supported initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to share its genetic material and health information for a long time, without any equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," he stated.

"In essence, our nation would provide the basic resources for medical research without any certainty that the end products would be accessible to our people if a future pandemic arise."

National Interest and International Frameworks

He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems previously set up through the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.

"This system is designed to ensure that when a nation provides its information, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We welcome continued dialogue with our American counterparts on how subsequent co-operation could be designed in a way that respects the independence and interests of both nations."

Medical Community Response

Medical experts expressed it recognised the government's concerns, but recommended that negotiations must proceed since a large portion of the nation's Aids initiatives were funded by international support.

"If technical issues exist, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and mutually agreed protections," it said.

The halted deal highlights the complex tensions between receiving much-needed international aid and safeguarding a country's data in an increasingly data-driven world.

About the author

Melanie Crawford DVM

A seasoned betting analyst with over a decade of experience in sports markets and casino gaming trends across Europe.

BetModernHub

Type to search articles.